Transcriptomics

Dataset Information

0

Proteasome Inhibition as a Therapeutic Approach in Atypical Teratoid/Rhabdoid Tumors

ABSTRACT: Generation of fpkm lists for 6 cell lines

ORGANISM(S): Homo sapiens

PROVIDER: GSE137777 | GEO | 2019/09/21

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Unknown Proteasome inhibition as a therapeutic approach in atypical teratoid/rhabdoid tumors.
| S-EPMC7236404 | biostudies-literature
Genomics Proteasome Inhibition as a Therapeutic Approach in Atypical Teratoid/Rhabdoid Tumors
| PRJNA573051 | ENA
Unknown MEK Inhibition Suppresses Growth of Atypical Teratoid/Rhabdoid Tumors.
| S-EPMC7821707 | biostudies-literature
Unknown Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors.
| S-EPMC7339881 | biostudies-literature
Unknown Ribavirin as a potential therapeutic for atypical teratoid/rhabdoid tumors.
| S-EPMC5814281 | biostudies-literature
Unknown Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors.
| S-EPMC5594561 | biostudies-literature
Unknown NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors.
| S-EPMC6714307 | biostudies-literature
Unknown Wnt pathway in atypical teratoid rhabdoid tumors.
| S-EPMC4483069 | biostudies-literature
Unknown MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumors.
| S-EPMC6954444 | biostudies-literature
Unknown Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors.
| S-EPMC7140067 | biostudies-literature